| Disparate unloading efficacy of the calcium channel blockers, verapamil and nifedipine, on the failing hypertensive left ventricle. | |
| | |
MedLine Citation:
|
PMID: 6375329 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Calcium channel blockers reduce arterial smooth muscle tone and lower blood pressure. They may be regarded as left ventricular (LV) unloading agents. LV unloading efficacy of nifedipine (15 patients) and verapamil (14 patients) was tested in hypertensive decompensated patients, during a 1-month treatment period. Nifedipine persistently reduced systemic vascular resistance (SVR), mean arterial pressure, mean pulmonary wedge pressure (PWP), and LV diastolic diameter, and improved cardiac index and velocity of circumferential fiber shortening (Vcf). All of the patients had relief from dyspnea and reduction in heart size. The only side effect was ankle edema in six. Verapamil reduced SVR and mean arterial pressure and was not effective on PWP, LV diastolic diameter, and Vcf. The drug was discontinued in two patients who developed severe dyspnea at rest after 3 to 4 days of continuous oral treatment. Clinical symptoms and signs did not improve in the remaining patients despite persistent pressure reduction. A less potent vasodilating action of verapamil and a prominent depression in cardiac contractility may account for the differential results with the two compounds, in spite of a shared vasodilating antihypertensive effect. These findings indicate that functional changes in the failing hypertensive heart may differ from one calcium blocker to another as a result of interaction and relative preponderance of influence on afterload and contractility. |
| | |
Authors:
|
M D Guazzi; C Cipolla; P Della Bella; F Fabbiocchi; P Montorsi; P Sganzerla |
Related Documents
:
|
3355809 - Effect of the calcium antagonist nifedipine on intraocular pressure in normal subjects. 3280299 - Hypertension in the emergency department. 7182089 - Treatment of hypertension in dialysis and essential hypertension patients with nifedipine. 6184569 - Verapamil compared with nifedipine in the treatment of essential hypertension. 2480849 - Functional and metabolic effects of ribose in combination with prazosin, verapamil and ... 2078319 - Antihypertensive effectiveness of nifedipine gastrointestinal therapeutic system in the... 21285669 - Potential benefits of aliskiren beyond blood pressure reduction. 1316399 - No inhibitory effect of increased serum magnesium upon pressor response to infused calc... 15671339 - Behavioural response to the bioavailability of inorganic mercury in the hydrothermal mu... |
Publication Detail:
|
Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: American heart journal Volume: 108 ISSN: 0002-8703 ISO Abbreviation: Am. Heart J. Publication Date: 1984 Jul |
Date Detail:
|
Created Date: 1984-07-26 Completed Date: 1984-07-26 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0370465 Medline TA: Am Heart J Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 116-23 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cardiac Output Clinical Trials as Topic Echocardiography Female Heart Failure / drug therapy, etiology, physiopathology* Heart Ventricles / physiopathology Humans Hypertension / complications* Male Middle Aged Myocardial Contraction* Nifedipine / therapeutic use* Pulmonary Wedge Pressure Vascular Resistance Verapamil / therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
21829-25-4/Nifedipine; 52-53-9/Verapamil |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: C1q-binding immune complexes and other immunological studies in children with pulmonary hemosiderosi...
Next Document: Clinical experience with rate-controlled delivery of antihypertensive therapy by a transdermal syste...